Moreover, 5-aza-2′-deoxycytidine, a demethylation reagent, could reverse DNA methylation of DYPD promoter and DYPD activity in 5-FU resistant ESCC cells (Lin K. et al., 2019). The gene discussed is DPYD; the disease is esophageal squamous cell carcinoma.